This inventor holds 32 USPTO granted patents, plus 2 CIPO patents. Top assignees: Abbott Laboratories Corporation, Merck Frosst Canada, Inc., Medivir Ab. Active years: 1986-2005.
Location History:
- Quebec, CA (1992)
- Dollard des Ormeaux, CA (1986 - 1993)
- Gurnee, IL (US) (1991 - 2005)
Company Filing History:
20 out of 4,186 
7 out of 212 
2 out of 120 
Years Active: 1986-2005
Areas of Expertise:
Title: The Innovative Contributions of Howard E. Morton
Introduction
Howard E. Morton, based in Gurnee, Illinois, is an esteemed inventor and researcher with a remarkable portfolio of 32 patents. His work has significantly advanced the fields of medicinal chemistry and pharmacology, making substantial contributions to drug development and synthesis methodologies.
Latest Patents
Among his latest patents, Howard E. Morton is known for his work on the "Synthesis of Acyclic Nucleoside Derivatives." This invention details methods and novel intermediates for preparing acyclic nucleoside derivatives, which are crucial for pharmaceutical applications. Another notable patent is the "Process for the Preparation of Cell Proliferation Inhibitors," which describes a process for synthesizing substituted indole cell proliferation inhibitors, playing a critical role in the development of therapeutic agents.
Career Highlights
Throughout his illustrious career, Howard has worked with prominent companies in the pharmaceutical industry, including Abbott Laboratories Corporation and Merck Frosst Canada, Inc. His expertise and innovative approach have led to the successful development of various healthcare solutions, significantly impacting patient care and treatment options.
Collaborations
Howard's collaborative spirit is evident in his partnerships with esteemed colleagues such as M. Robert Leanna and Anthony Ralph Haight. These collaborations have fostered a creative research environment, leading to breakthrough inventions and advancements in pharmaceutical chemistry.
Conclusion
In summary, Howard E. Morton has established himself as a key figure in the realm of innovations and inventions within the pharmaceutical industry. His extensive patent portfolio and collaborative efforts underscore his commitment to advancing science and improving health outcomes globally.